SCHEMBL17539128

SCHEMBL17539128

CCOC(=O)[C@H]1Cc2ccc(CN(C)C(=O)OC(C)(C)C)cc2C1=O

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.56
MAPT P10636 2/20 0.56
ALDH1A1 P00352 2/20 0.56
KMT2A Q03164 2/20 0.56
MEN1 O00255 1/20 0.56
GAA P10253 1/20 0.56
HPGD P15428 1/20 0.56
HSD17B10 Q99714 1/20 0.56
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
MCHR1 Q99705 1/20 0.33
GLS O94925 1/20 0.33
HTR2C P28335 1/20 0.33
SLC6A4 P31645 1/20 0.33
METAP1 P53582 1/20 0.33
ACHE P22303 1/20 0.32
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17539083 1.00 KDM4E (0.56) KDM4EMAPTALDH1A1KMT2AMEN1
SCHEMBL17539087 0.92 KDM4E (0.56) KDM4EMAPTALDH1A1KMT2AMEN1
SCHEMBL17509613 0.87 HTR2C (0.37) KDM4EMAPTALDH1A1KMT2AMEN1
SCHEMBL17509606 0.78 HTR2C (0.37) KDM4EMAPTALDH1A1KMT2AMEN1
SCHEMBL17539152 0.77 NFKB1 (0.37) KDM4EMAPTALDH1A1KMT2AMEN1
SCHEMBL16153700 0.76 MAPT (0.76) KDM4EMAPTALDH1A1KMT2AMEN1
SCHEMBL17539082 0.75 GPR119 (0.41) MCHR1GLSHTR2CSLC6A4
SCHEMBL17539116 0.75 NFKB1 (0.37) KDM4EMAPTALDH1A1KMT2AMEN1
SCHEMBL6383092 0.73 ALDH1A1 (0.70) KDM4EMAPTALDH1A1KMT2AMEN1
SCHEMBL19236010 0.71 MCHR1 (0.39) MCHR1GLSHTR2CSLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016025681-A1 INHIBITORS OF HIV-1 ENTRY AND METHODS OF USE THEREOF THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2016-02-18 WO disclosed